Abstract
Studies on isolated perfused rat hearts indicate that uric acid together with other dephosphorylated purine metabolites is released into the perfusate where it represents the major degradation product of purine nucleotidcs under basal conditions (Ronca-Testoni and Borghini, 1982a). During hypoxia, anoxia or ischaemia a very strong increase in purine release has been observed but in these conditions the contribution of the other purine derivatives (inosine and adenosine) to total purine release is higher than that of uric acid (Achterberg et al., 1986). The ability of the rat heart to degrade adenine compounds down to uric acid is explained by the presence of xanthine oxidase in the heart and recently this enzyme has been seen mainly localized on vascular endothelial cells (Gerlach et al., 1985). These cells as well as cardiomyocytes exhibit synthesis of purine nucleotides by active salvage pathways, in particular through hypo-xanthine guanine phosphoribosyltransferase (HGPT, EC 2.4.2.8) activity. Xanthine oxidase partially subtracts the purine ring from the salvage pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achterberg, P.W., Stroeve, R.J., and de Jong, J.W., 1986, Myocardial ade-nosine cycling rates during normoxia and under conditions of stimulated purine release, Biochem. J., 235: 13.
de Jong, J.W., Czarneck, W., Huizer, P.W., and Serruys, K., 1987, Urate production by human heart, Eur. Heart J., 8: 22.
Gerlach, E., Nees, S., and Beker, B.F., 1985, The vascular endothelium: a survey of some newly evolving biochemical and physiological features, Basic Res. Cardiol. 80: 459.
Harmsen, E., de Jong, J.W., and Serruys, P.W., 1981, Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines, Clin. Chim. Acta, 115: 73.
Henry, R.J., 1964, “Clinical Chemistry: principles and technics”, Harper & Row, New York.
McCord, J. M., 1985, Oxygen-derived free radicals in postischemic tissue injury, New Engl. J. Med., 312: 159.
Ronca-Testoni, S. and Borghini, F., 1982a, Release of uric acid from perfused rat heart, It. J. Biochem., 31: 127.
Ronca-Testoni, S. and Borghini, F., 1982b, Degradation of perfused adenine compounds up to uric acid in isolated rat heart, J. Mol. Cell. Cardiol., 14: 177.
Sakuma, R., Nishina, T., and Kitamura, M., 1987, Deproteinizing methods evaluated for determination of uric acid in serum by reverse-phase liquid chromatography with ultraviolet detection, Clin. Chem., 33: 1427.
Watts, R.W.E., Watts, J.E.M., and Seegmiller, J.E., 1965, Xanthine oxidase activity in human tissues and its inhibition by allopurinol, J. Lab. Clin. Med., 66: 688.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Ronca, G. et al. (1989). Uric Acid and Purine Compounds in Aortic and Coronary Sinus Blood in Man. In: Mikanagi, K., Nishioka, K., Kelley, W.N. (eds) Purine and Pyrimidine Metabolism in Man VI. Advances in Experimental Medicine and Biology, vol 253A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5673-8_63
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5673-8_63
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5675-2
Online ISBN: 978-1-4684-5673-8
eBook Packages: Springer Book Archive